Suzetrigine (Journavx; Vertex Pharmaceuticals) received approval from the FDA for the treatment of adults with moderate-to-severe acute pain, …
Source: pain relief
In that study, 82% of surgical patients and 91% of nonsurgical patients said suzetrigine was good, very good or excellent at treating their pain.
Source: best pain reliever
Journavx is the first FDA-approved pain medication in decades that does not rely on opioid receptors to manage pain. … nerve pain. Despite this …
Source: nerve pain medication
